Think Outside the Lyme Box: Optic Neuropathy and Polyarthritis Caused by Borrelia miyamotoi [PDF]
Borrelia miyamotoi disease (BMD) is an emerging tick-borne infection that can cause a range of symptoms. While typically presenting as an acute febrile illness, less common but significant complications, such as optic neuropathy, can occur. We describe a
Ken Nagahata, T. Ikeda, Yoshihisa Tsuji
semanticscholar +2 more sources
Combining citizen science and molecular diagnostic methods to investigate the prevalence of Borrelia burgdorferi s.l. and Borrelia miyamotoi in tick pools across Great Britain [PDF]
Lyme disease is the most common tick-borne disease and is caused by a group of bacteria known as Borrelia burgdorferi sensu lato (s.l.) complex. Sharing the same genus as B.
J. Shan +4 more
semanticscholar +2 more sources
Case report: First case of Borrelia miyamotoi meningitis in an immunocompromised patient in Norway [PDF]
Background Tick-borne disease caused by B. miyamotoi (BMD) usually manifest as a febrile illness in humans. Complications include relapsing fever and in rare occasions involvement of the central nervous system.
T. Schwartz +4 more
semanticscholar +2 more sources
Borrelia miyamotoi FbpA and FbpB Are Immunomodulatory Outer Surface Lipoproteins With Distinct Structures and Functions [PDF]
Pathogens that traffic in the blood of their hosts must employ mechanisms to evade the host innate immune system, including the complement cascade. The Lyme disease spirochete, Borreliella burgdorferi, has evolved numerous outer membrane lipoproteins ...
C. E. Booth +3 more
semanticscholar +2 more sources
Borrelia miyamotoi in wild rodents from four different regions of Turkey. [PDF]
Borrelia miyamotoi is a tick-borne zoonotic agent that causes hard tick-borne relapsing fever, an emerging disease in humans. Some small mammalian and bird species are reported to be reservoirs of B. miyamotoi. This study aims to examine Borrelia species
B. Çelebi +10 more
semanticscholar +3 more sources
Borrelia miyamotoi in Human-Biting Ticks, United States, 2013–2019 [PDF]
During 2013–2019, Borrelia miyamotoi infection was detected in 19 US states. Infection rate was 0.5%–3.2%; of B. miyamotoi–positive ticks, 59.09% had concurrent infections. B.
Guang Xu +5 more
doaj +2 more sources
In Vitro Antimicrobial Susceptibility of Clinical Isolates of Borrelia miyamotoi [PDF]
ABSTRACT Borrelia miyamotoi is an emerging relapsing fever (RF) Borrelia species that is reported to cause human disease in regions in which Lyme borreliosis is endemic. We recently showed that B. miyamotoi tick isolates are resistant to amoxicillin in vitro
Joris Koetsveld +10 more
openaire +3 more sources
Borrelia miyamotoi–Associated Neuroborreliosis in Immunocompromised Person
Borrelia miyamotoi is a newly recognized human pathogen in the relapsing fever group of spirochetes. We investigated a case of B. miyamotoi infection of the central nervous system resembling B. burgdorferi-induced Lyme neuroborreliosis and determined that this emergent agent of central nervous system infection can be diagnosed with existing methods.
Katharina Boden +4 more
openaire +4 more sources
Identification of immunoreactive linear epitopes of Borrelia miyamotoi
Abstract Borrelia miyamotoi is an emerging tick-borne spirochete transmitted by Ixodid ticks. Current serologic assays for B. miyamotoi are impacted by genetic similarities to other Borrelia ...
Tokarz, Rafal +10 more
openaire +3 more sources
Borrelia miyamotoi infection in nature and in humans [PDF]
Borrelia miyamotoi is a relapsing fever Borrelia group spirochete that is transmitted by the same hard-bodied (ixodid) tick species that transmit the agents of Lyme disease. It was discovered in 1994 in Ixodes persulcatus ticks in Japan. B. miyamotoi species phylogenetically cluster with the relapsing fever group spirochetes, which usually are ...
Krause, PJ +3 more
openaire +5 more sources

